Viehbacher’s contract will see the incoming helmsman receive a yearly base salary of $1.6 million. He’ll also be up to take part in Biogen’s management incentive plan and receive a bonus with an annual target of 150% of salary, Biogen said in its securities filing. Viehbacher is in line to receive $11.2 million in stock as a one-time bonus paid out over three years and up to $16.8 million in performance-based stock compensation that will pay out based on shareholder returns.
Additionally, he's slated to buy $2 million in stock and Biogen is giving him $2 million more in stock available to vest three years later.
overall sales for the third quarter clocked in at $2.5 billion, down 8% over the same stretch in 2021.
Additionally, he's slated to buy $2 million in stock and Biogen is giving him $2 million more in stock available to vest three years later.
overall sales for the third quarter clocked in at $2.5 billion, down 8% over the same stretch in 2021.